Medical Therapies Limited

ASX:MTY ISIN:AU000000MTY8

Feb 10, 2012

OVERVIEW | NEWS | MULTIMEDIA | RESEARCH

Medical Therapies Limited Company Summary

Medical Therapies Limited is an Australian pharmaceutical development company committed to the commercialisation of its drug candidates for cancer and anti-inflammatory conditions including cholecystitis, and distal proctitis. The Company's patent-protected technologies include a number of metal complexes of anti-inflammatory drugs showing increased safety and reduced toxicity in pre-clinical trials. Medical Therapies has also been active is seeking complementary technologies to its existing anti-cancer and anti-inflammatory portfolio.

COMPANY DATA

	Headquarters	Level 6, 40 King Street

		SYDNEY NSW 2000, AUSTRALIA

	Telephone	+61 2 9299 0311

	Fax	+61 2 9299 2198

	Principal Sector	Health & Pharm

	Principal Industry	Biotechnology

	Homepage	www.medicaltherapies.com.au

Key Developments: Medical Therapies Limited

	Medical Therapies Limited (ASX:MTY) Announce Positive Interim Results From Cuprindo Phase I Clinical Trials FEB 15, 2008 14:07 - Article Views: 1,343 Medical Therapies Limited (ASX: MTY), today announced that it has completed its 'first-in-human' clinical trial of Cuprindo(tm) to determine its safety, tolerability and systemic absorption characteristics. The Phase 1 trial was conducted using a topical suppository formulation in preparation for a planned efficacy study in proctitis patients.